-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 5, the diagnosis and treatment in the Hepatobiliary Surgery Inpatient Department of the East Branch of the First Affiliated Hospital of Xi'an Jiaotong University (Yanliang District) was in order.
After he came to the hospital, Director Sha Huanchen examined him.
Mr.
Director Sha Huanchen immediately submitted an application for MDT (multidisciplinary diagnosis and treatment) consultation to the Department of Hepatobiliary Surgery of the hospital.
Therefore, Director Sha Huanchen immediately organized the surgical team to formulate a detailed surgical plan, and communicated the surgical risks with the patients and their families at the same time
"Because there are abundant blood vessels in the human liver, the most risky risk during surgery is uncontrollable bleeding, which can lead to death or organ failure of the patient
After perfecting the preoperative preparations, on January 5, associate professor Sha Huanchen, director of hepatobiliary surgery, and chief physician Xu Kedong, the surgical team, based on the surgical plan formulated before the operation, with the cooperation of multiple disciplines such as the anesthesia surgery department, after more than 3 hours of intense and orderly work The operation successfully completed the resection of the huge liver tumor, and the intraoperative blood loss was only 200ML
Director Sha Huanchen once again reminded that liver cancer is a malignant tumor of the liver with insidious onset.
